Home » COTHERIX SEES HIGHER 2006 SPENDING
COTHERIX SEES HIGHER 2006 SPENDING
Biopharmaceutical
company CoTherix Inc. on Wednesday raised its full-year expense outlook, partly
due to a licensing pact it signed with Japanese drug developer Asahi Kasei Pharma
Corp.
The
Houston Chronicle
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May